MANCINI, ILARIA
MANCINI, ILARIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Acquired Thrombotic Thrombocytopenic Purpura Occurring in Advanced Age : Impact of a Delayed Onset on Disease Expression
2019 P. Agosti, I. Mancini, S. Pontiggia, B. Ferrari, M. Biganzoli, A. Artoni, S.M. Trisolini, L. Facchini, C. Caria, F. Peyvandi
ADAMTS13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
2012 G. Bettoni, R. Palla, C. Valsecchi, D. Consonni, L.A. Lotta, S.M. Trisolini, I. Mancini, K.M. Musallam, F.R. Rosendaal, F. Peyvandi
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis
2021 M.T. Pagliari, M. Boscarino, A. Cairo, I. Mancini, I. Martinelli, P. Bucciarelli, F. Rossi, F.R. Rosendaal, F. Peyvandi
ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
2013 I. Mancini
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura
2017 I. Mancini, B. Ferrari, C. Valsecchi, S. Pontiggia, M. Fornili, E. Biganzoli, F. Peyvandi
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
2018 E. Roose, G. Vidarsson, K. Kangro, O.J.H.M. Verhagen, I. Mancini, L. Desender, I. Pareyn, N. Vandeputte, A. Vandenbulcke, C. Vendramin, A. Schelpe, J. Voorberg, M. Azerad, L. Gilardin, M. Scully, D. Dierickx, H. Deckmyn, S.F. De Meyer, F. Peyvandi, K. Vanhoorelbeke
Case report : use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura
2012 L.A. Lotta, I. Mancini, G. Tuana, K.M. Musallam, F. Peyvandi
Congenital and acquired ADAMTS13 deficiency: two mechanisms, one patient
2015 B. Ferrari, A. Cairo, S. Pontiggia, I. Mancini, L. Masini, F. Peyvandi
Different clinical severity of first episodes and recurrence of thrombotic thrombocytopenic purpura
2010 L.A. Lotta, M.G. Mariani, D. Consonni, I. Mancini, R. Palla, A. Maino, D. Vucelic, M. Pizzuti, P.M. Mannucci, F. Peyvandi
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
2020 M. Capecchi, C. Mocellin, C. Abbruzzese, I. Mancini, D. Prati, F. Peyvandi
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity
2019 C. Valsecchi, M. Mirabet, I. Mancini, M. Biganzoli, L. Schiavone, S. Faraudo, D. Mane-Padros, D. Giles, J. Serra-Domenech, S. Blanch, S.M. Trisolini, L. Facchini, E. Rinaldi, F. Peyvandi
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-Tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients
2014 I. Mancini, C. Valsecchi, L.A. Lotta, L. Deforche, S. Pontiggia, M. Bajetta, R. Palla, K. Vanhoorelbeke, F. Peyvandi
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
2018 A. Schelpe, E. Roose, B.S. Joly, I. Pareyn, I. Mancini, M. Biganzoli, H. Deckmyn, J. Voorberg, R. Fijnheer, F. Peyvandi, S.F. De Meyer, P. Coppo, A. Veyradier, K. Vanhoorelbeke
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura
2016 I. Mancini, I. Ricano-Ponce, E. Pappalardo, A. Cairo, M.M. Gorski, G. Casoli, B. Ferrari, M. Alberti, D. Mikovic, M. Noris, C. Wijmenga, F. Peyvandi, E. Rinaldi, A. Melpignano, S. Campus, R.A. Podda, C. Caria, A. Caddori, E. Di Francesco, G. Giuffrida, V. Agostini, U. Roncarati, C. Mannarella, A. Fragasso, G.M. Podda, E. Bertinato, A.M. Cerbone, A. Tufano, G. Loffredo, V. Poggi, M. Pizzuti, G. Re, M. Ronchi, K. Codeluppi, L. Facchini, A. De Fanti, S. Amarri, S.M. Trisolini, S. Capria, L. Aprile, M. Defina, S. Ceru
Lombardy Network for the Study and Treatment of Patients Undergoing Apheresis
2020 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, L. Barcella, A. Falanga, F. Peyvandi
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
2020 S. Riva, I. Mancini, A. Maino, B. Ferrari, A. Artoni, P. Agosti, F. Peyvandi
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura
2014 L.A. Lotta, C. Valsecchi, S. Pontiggia, I. Mancini, A. Cannavò, A. Artoni, D. Mikovic, G. Meloni, F. Peyvandi
Measurement of anti-ADAMTS13 neutralising autoantibodies: a comparison between CBA and FRET assays
2012 I. Mancini, C. Valsecchi, R. Palla, L.A. Lotta, F. Peyvandi
Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis
2018 M.M. Gorski, H.G. de Haan, I. Mancini, L.A. Lotta, P. Bucciarelli, S.M. Passamonti, A. Cairo, E. Pappalardo, A. van Hylckama Vlieg, I. Martinelli, F.R. Rosendaal, F. Peyvandi